Accessing investigational anticancer agents outside of clinical trials

Am J Health Syst Pharm. 1998 Apr 1;55(7):651-2, 660. doi: 10.1093/ajhp/55.7.651.

Authors

M J Montello¹, J J Greenblatt, A Fallavollita, D Shoemaker

Affiliation

¹ Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA. [email protected]

PMID: 9558419
DOI: 10.1093/ajhp/55.7.651

No abstract available

MeSH terms

Antineoplastic Agents / therapeutic use*
Drugs, Investigational / therapeutic use*
Health Services Accessibility
Humans
National Institutes of Health (U.S.)
Neoplasms / drug therapy*
Pharmaceutical Services
Salvage Therapy*
Vereinigte Staaten

Substances

Antineoplastic Agents
Drugs, Investigational